TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
ProPharma Group Sweden AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 97,444 | 96,813 | 97,415 |
Financial expenses | 14 | 277 | 286 |
Earnings before taxes | -4,982 | 4,822 | 14,721 |
EBITDA | -4,794 | 5,421 | 15,492 |
Total assets | 52,606 | 44,900 | 47,975 |
Current assets | 51,936 | 44,055 | 46,807 |
Current liabilities | 26,801 | 14,113 | 21,220 |
Equity capital | 22,505 | 26,648 | 22,880 |
- share capital | 100 | 100 | 100 |
Employees (average) | 65 | 57 | 62 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 42.8% | 59.3% | 47.7% |
Turnover per employee | 1,499 | 1,698 | 1,571 |
Profit as a percentage of turnover | -5.1% | 5.0% | 15.1% |
Return on assets (ROA) | -9.4% | 11.4% | 31.3% |
Current ratio | 193.8% | 312.2% | 220.6% |
Return on equity (ROE) | -22.1% | 18.1% | 64.3% |
Change turnover | 631 | -602 | 12,212 |
Change turnover % | 1% | -1% | 14% |
Chg. No. of employees | 8 | -5 | 1 |
Chg. No. of employees % | 14% | -8% | 2% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.